Renal neoplasms with TSC/mTOR pathway mutations
Jump to navigation
Jump to search
Renal neoplasms with TSC/mTOR pathway mutations is a diverse group of kidney tumours.
Kidney tumours with TSC/mTOR mutations:
- Renal cell carcinoma with fibromyomatous stroma.[1]
- Eosinophilic solid and cystic renal cell carcinoma.[2]
- Eosinophilic vacuolated tumour.[2]
- Low-grade oncocytic tumour.[2]
References
- ↑ Shah RB, Mehra R (March 2024). "Renal Cell Carcinoma Associated With TSC/MTOR Genomic Alterations: An Update on its Expanding Spectrum and an Approach to Clinicopathologic Work-up". Adv Anat Pathol 31 (2): 105–117. doi:10.1097/PAP.0000000000000419. PMID 37899532.
- ↑ 2.0 2.1 2.2 Pivovarcikova K, Alaghehbandan R, Vanecek T, Ohashi R, Pitra T, Hes O (January 2022). "TSC/mTOR Pathway Mutation Associated Eosinophilic/Oncocytic Renal Neoplasms: A Heterogeneous Group of Tumors with Distinct Morphology, Immunohistochemical Profile, and Similar Genetic Background". Biomedicines 10 (2). doi:10.3390/biomedicines10020322. PMC 8869370. PMID 35203531. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8869370/.